Softball Athlete Suspended for the Presence of Pseudoephedrine
The Canadian Centre for Ethics in Sport (CCES) announced today that Mitchell McKay, a softball athlete, received an 18-month sanction for an anti-doping rule violation. The athlete’s urine sample, collected in-competition on August 2, 2023, revealed the presence of pseudoephedrine, a prohibited specified stimulant.
In response to the CCES’s notification of the adverse analytical finding, the athlete signed an Agreement on Consequences thereby waiving their right to a hearing and accepting the proposed sanction and all other applicable consequences. Because the athlete accepted a voluntary provisional suspension on September 7, 2023, the sanction ends on March 6, 2025.
During the sanction period, the athlete is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program (CADP), including training with teammates.
In compliance with rule 8.4 of the CADP, the CCES’s file outcome summary can be found in the Canadian Sport Sanction Registry.
